Preclinical testing of oncolytic adenovirus sensitivity in patient-derived tumor organoids

Summary: Patient-derived organoids (PDOs) have shown the potential to reflect patient sensitivity to chemotherapeutic or targeted drugs. Recently, we showed that organoid models can also serve as a platform to screen for selectivity and potency of oncolytic adenoviruses (OAds). In this protocol, we...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Silvia Pascual-Sabater, Giulia Raimondi, Ana Mato-Berciano, Eva C. Vaquero, Fabio Ausania, Cristina Fillat
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2021-12-01
Serija:	STAR Protocols
Teme:	Biotechnology and bioengineering Cancer Health Sciences Organoids
Online dostop:	http://www.sciencedirect.com/science/article/pii/S2666166721007231
Oznake:	Označite Brez oznak, prvi označite!